A glycopeptide vaccine STn-KLH based on conjugated MUC1 glycopeptides and glycoforms of Tn and S-Tn induced antibody responses in mice but failed to improve OS for breast cancer patients [15]. This evidence concerns the gene MUC1 and breast carcinoma.